Philip is an experienced strategy and operations consulting executive with over 20 years of biopharmaceutical industry experience. Philip has deep expertise in the areas of new product strategy and commercial excellence. He has executed several successful engagements in the areas of product launch strategy, brand and portfolio strategy, and life cycle planning.
Prior to joining RxC, Philip held leadership positions at Cello Health BioConsulting and Campbell Alliance where he was responsible for leading the East Coast strategic consulting business. Philip has expertise across multiple therapeutic areas including rare diseases, oncology, and specialty biopharma. Throughout his career, Philip has worked with clients ranging from early-stage to world leading companies to identify growth opportunities.
Philip holds a Bachelor of Science in Physiology and Neuroscience from the University of California, San Diego. He also earned an MBA in Strategy and Finance with Dean’s List and Beta Gamma Sigma distinctions from the Marshall School of Business at the University of Southern California.